DeepMind and Isomophic Labs recently published the methods behind AlphaFold3, the sequel to the famous AlphaFold2. The involvement of Isomorphic Labs signifies a shift that Alphabet is getting serious about drug design. To this end, AlphaFold3 provides a substantial improvement in the field of complex prediction, a major piece in the computational drug design pipeline.